A method of preventing gait abnormalities in a patient with Parkinson's disease or of improving or restoring to normal the gait of a patient with Parkinson's disease, comprising the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve or restore to normal said gait, said one or more hepatocyte growth factor mimics having a general structural formula 1 2 3 where Ri is one of an N-acyl group, a substituted or unsubstituted phenyl, a norleucine group, and an amino acid selected from tyrosine, phenylalanine, aspartic acid, arginine, isoleucine, serine, histidine, glycine, cysteine, methionine, tryptophan, lysine norvaline, ornithine, and s-benzyl cysteine
Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes
Tappeiner C, Walscheid K, Heiligenhaus A
Rao YF, Chen W, Liang XG, Huang YZ, Miao J, Liu L, et al
The serum fetal Zn level does not appear to significantly affect the transplacental transfer from the mother to the fetus when in situ perfused placentas from guinea pigs are utilized ( Zn placenta absorption when mother is Zn deficient Zn deficiency worldwide is common and is encountered more frequently in lower income countries
